Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.7B | 1.8B | 1.8B | 1.6B |
| Cost of revenue | 1.3B | 1.1B | 962M | 1.0B |
| Gross profit | 1.4B | 641M | 840M | 587M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | -9M |
| Other operating expenses | — | — | — | — |
| Operating income | 925M | 243M | 437M | 188M |
| Non operating interest income | ||||
| Income | — | 5M | 9M | 9M |
| Expense | 255M | 243M | 246M | 243M |
| Other income expense | 50M | -31M | -186M | 214M |
| Pretax income | 720M | -26M | 14M | 168M |
| Tax provision | 119M | -199M | -9M | 21M |
| Net income | 601M | 173M | 23M | 147M |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 1.3B | 572M | 783M | 529M |
| Net income from continuing op. | 601M | 173M | 23M | 147M |
| Minority interests | — | 0 | -1M | — |
| Preferred stock dividends | — | — | — | — |